Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.34 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13770796 | 1.00 | CES2 (0.34) | CES2TAS2R46PTPN1 | |
| SCHEMBL12641991 | 1.00 | CES2 (0.34) | CES2TAS2R46PTPN1 | |
| SCHEMBL17634349 | 0.84 | PTPN1 (0.42) | CES2TAS2R46PTPN1 | |
| SCHEMBL6696664 | 0.84 | PTPN1 (0.42) | CES2TAS2R46PTPN1 | |
| Hydrogen Peroxide SCHEMBL5076367 | 0.79 | CES2 (0.40) | CES2TAS2R46 | |
| SCHEMBL13770795 | 0.79 | CES2 (0.40) | CES2TAS2R46 | |
| SCHEMBL13771155 | 0.79 | CES2 (0.40) | CES2TAS2R46 | |
| SCHEMBL1446617 | 0.79 | CES2 (0.40) | CES2TAS2R46 | |
| SCHEMBL12305441 | 0.79 | CES2 (0.40) | CES2TAS2R46 | |
| SCHEMBL14747987 | 0.79 | CES2 (0.40) | CES2TAS2R46 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214918-A1 | FUNCTIONALIZATION OF TERPENES BY SELECTIVE DEPROTONATION FOR THE SYNTHESIS OF (+)-ARTEMISININ AND RELATED COMPOUNDS | UNIV TEXAS (US) | 2025-07-03 | — | — | US | disclosed |
| WO-2023225681-A9 | S HOPINGFUNCTIONALIZATION OF TERPENES BY SELECTIVE DEPROTONATION FOR THE SYNTHESIS OF (+)-ARTEMISININ AND RELATED COMPOUNDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYTEM (US) | 2024-03-21 | — | — | WO | disclosed |
| WO-2023225681-A2 | S HOPINGFUNCTIONALIZATION OF TERPENES BY SELECTIVE DEPROTONATION FOR THE SYNTHESIS OF (+)-ARTEMISININ AND RELATED COMPOUNDS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYTEM (US) | 2023-11-23 | — | — | WO | disclosed |
| CN-114231655-A | SNP locus linked with artemisinin content and application thereof | 华智生物技术有限公司 | 2022-03-25 | — | — | CN | disclosed |
| CN-114214451-A | SNP locus linked with artemisinin content and application thereof | 华智生物技术有限公司 | 2022-03-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214918-A1 | FUNCTIONALIZATION OF TERPENES BY SELECTIVE DEPROTONATION FOR THE SYNTHESIS OF (+)-ARTEMISININ AND RELATED COMPOUNDS | DHPS, SQLE, CYP11B2 | CES2 2460/4885TAS2R46 1871/4885PTPN1 4845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.